Changes

=== Diagnostic and assessment tools:  ===

=== Diagnostic and assessment tools:  ===

<div style='text-align:justify;'>Kaphadosha can be assessed by clinical features and functions through subjective methods like questionnaires and objective methods. Currently, there are no validated and standardized tools for dosha assessment within the body. Kaphavriddhi and kshaya features will be assessed through a subjective questionnaire.Ayurvedic physicians assess the normalcy and abnormality through the ayurvedic principles of examination (pariksha). <br/>Subjective and objective methods which may be used to assess the normalfunctioning of kapha are:  

<div style='text-align:justify;'>Kaphadosha can be assessed by clinical features and functions through subjective methods like questionnaires and objective methods. Currently, there are no validated and standardized tools for [[Dosha|dosha]] assessment within the [[Sharira|body]]. Kaphavriddhi and kshaya features will be assessed through a subjective questionnaire. Ayurvedic physicians assess the normalcy and abnormality through the ayurvedic principles of examination (pariksha). <br/>Subjective and objective methods which may be used to assess the normal functioning of kapha are:  

<ul><li>Test for assessment for muscular strength and endurance likedynamometry<ref name="ref11">Baltzopoulos V, Brodie DA. Isokinetic dynamometry. Applications and limitations. Sports Med. 1989 Aug;8(2):101-16.</ref> and  6 minute walk test<ref name="ref12">Agarwala P, Salzman SH. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement. Chest. 2020 Mar;157(3):603-611.</ref>, etc. </li>

<ul><li>Test for assessment for muscular strength and endurance like dynamometry<ref name="ref11">Baltzopoulos V, Brodie DA. Isokinetic dynamometry. Applications and limitations. Sports Med. 1989 Aug;8(2):101-16.</ref> and  6 minute walk test<ref name="ref12">Agarwala P, Salzman SH. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement. Chest. 2020 Mar;157(3):603-611.</ref>, etc. </li>

<li>Cardio- Pulmonary exercise tests<ref name="ref13">Aguilaniu B, Wallaert B. Illustrated interpretation of cardio-pulmonary exercise testing. Rev Mal Respir. 2013 Dec;30(10):812-3.</ref>. </li>

<li>Cardio- Pulmonary exercise tests<ref name="ref13">Aguilaniu B, Wallaert B. Illustrated interpretation of cardio-pulmonary exercise testing. Rev Mal Respir. 2013 Dec;30(10):812-3.</ref>. </li>

<li>Lipid profile<ref name="ref14">Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF, Masana L, Mangas A, Hernandez-Mijares A, Gonzalez-Santos P, Ascaso JF. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vascular health and risk management. 2009;5:757.</ref>, adiponectin<ref name="ref15">Achari AE, Jain SK. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int J Mol Sci. 2017 Jun 21;18(6):1321.</ref> for assessment of meda. </li>

<li>Lipid profile<ref name="ref14">Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF, Masana L, Mangas A, Hernandez-Mijares A, Gonzalez-Santos P, Ascaso JF. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vascular health and risk management. 2009;5:757.</ref>, adiponectin<ref name="ref15">Achari AE, Jain SK. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int J Mol Sci. 2017 Jun 21;18(6):1321.</ref> for assessment of meda. </li>

<li>Dual-energy X-ray absorptiometry<ref name="ref16">Laskey MA. Dual-energy X-ray absorptiometry and body composition. Nutrition. 1996 Jan 1;12(1):45-51.</ref> </li>

<li>Dual-energy X-ray absorptiometry<ref name="ref16">Laskey MA. Dual-energy X-ray absorptiometry and body composition. Nutrition. 1996 Jan 1;12(1):45-51.</ref> </li>

<li>Bioelectrical impedance devices to measure body fat percent (BF%), fat mass (FM), and fat-free mass (FFM).<ref name="ref17">Ward LC. Bioelectrical impedance analysis for body composition assessment: reflections on accuracy, clinical utility, and standardisation. Eur J Clin Nutr. 2019 Feb;73(2):194-199.</ref> </li>

<li>Bioelectrical impedance devices to measure [[Sharira|body]] fat percent (BF%), fat mass (FM), and fat-free mass (FFM).<ref name="ref17">Ward LC. Bioelectrical impedance analysis for [[Sharira|body]] composition assessment: reflections on accuracy, clinical utility, and standardisation. Eur J Clin Nutr. 2019 Feb;73(2):194-199.</ref> </li>

<li>Electro-gustometry<ref name="ref18">Stillman JA, Morton RP, Hay KD, Ahmad Z, Goldsmith D. Electrogustometry: strengths, weaknesses, and clinical evidence of stimulus boundaries. Clin Otolaryngol Allied Sci. 2003 Oct;28(5):406-10.</ref> </li>

<li>Electro-gustometry<ref name="ref18">Stillman JA, Morton RP, Hay KD, Ahmad Z, Goldsmith D. Electrogustometry: strengths, weaknesses, and clinical evidence of stimulus boundaries. Clin Otolaryngol Allied Sci. 2003 Oct;28(5):406-10.</ref> </li>

<li>CSF examination<ref name="ref19">Bigner SH. Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications. Journal of neuropathology and experimental neurology. 1992 Mar 1;51(3):235-45.</ref></li>

<li>CSF examination<ref name="ref19">Bigner SH. Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications. Journal of neuropathology and experimental neurology. 1992 Mar 1;51(3):235-45.</ref></li>